Insider · CIK 0001622297
Hubert C Chen
Files at VKTX (Viking Therapeutics, Inc.). First filing -, latest -.
Hubert C Chen files SEC Form 4 as officer at VKTX (Viking Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hubert C Chen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | VKTX Viking Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +190,000 | $0.00 | $0 | 190,000 | Jun 3, 2026 |
Questions about Hubert C Chen
Answered from the filings on this page, as of the latest one.
Is Hubert C Chen buying or selling?
Hubert C Chen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hubert C Chen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hubert C Chen has 0.
Where does Hubert C Chen file Form 4?
Hubert C Chen has filed Form 4 at VKTX (Viking Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.